Advances in Bioanalytics and Biomarkers

(1012-A) A novel single-cell fluorescence microscopy-based analysis for the detection of biomarkers of cellular senescence

(1029-B) Characterization of membrane protein using mass spectrometry-based technologies — affinity selection-mass spectrometry (AS-MS)

(1034-C) Doing more with less: Application of microsampling, LC/MS/MS and MS imaging for the measurement of drug, metabolites and lipid biomarkers in biofluids and tissues

(1035-D) Free cysteine profiling confirmed STING target engagement and identified potential covalent off-targets for a novel STING inhibitor

(1046-C) HymonBio’s Leading PCR Trends: MoLock and One-Step Technology

(1053-B) High-throughput intact protein analysis using Acoustic Ejection Mass Spectrometry (AEMS) on a quadrupole time of flight mass spectrometer

(1090-C) Development of Tumor and Blood Pharmacodynamic Assays to Support Development of IACS-53152, a Protein Arginine Methyltransferase 1 Inhibitor

(1092-A) Paper-Based Vertical Flow Immunoassay for the Point-of-Care Multiplex Detection of Radiation Dosimetry Genes

(1172-A) Laser-treated thermoplastic carbon electrodes for enhanced performance of electrochemical sensors

(1262-C) Development and characterization of a novel monoclonal antibody to Tau p217 in Alzheimer’s disease murine models and human disease tissue

(1265-B) Development of a cross platform IR-MALDESI front end for high throughput ToF Mass Spectrometry

(1297-B) Generating affinity reagents to phosphoepitopes by phage-display

(1363-D) quantum-based sensing of microRNA biomarkers of breast cancer using NV-center nanodiamonds.

(1387-D) Towards a plasmonic nanosieving device for the automated selection of cancer-relevant peptides targeted by T-cell receptor-mimic antibodies

(1389-B) Ultra-High Throughput Sample Quality control enabled by Sciex Acoustic Ejection Mass Spectrometry (AE-HRMS) Technology